The heterogenicity of mucinous colorectal adenocarcinoma and its association with prognosis

doi:10.3877/cma.j.issn.2095-3224.2016.05.012

Abstract

Abstract:

To discuss the heterogenicity of mucinous colorectal adenocarcinoma in respect of clinicopathological and molecular pathology. Review of the relevant literatures combining with our experience of pathological diagnosis, we summarize the morphological characteristics, the status of microsatellite and the effect on the prognosis of patients with mucinous colorectal adenocarcinoma. There are obvious difference among the morphological characteristics and the status of microsatellite in the patients with mucinous colorectal adenocarcinoma, which cause different clinic biologic behaviors, different response to treatment and so different prognosis. Mucinous colorectal adenocarcinoma is a kind of heterogeneous cancer. The precise diagnosis combining with the morphology and molecular pathology drawed by the pathologists, which is benefit to select the therapeutic regimen and helpful for prognostic stratification for the patients.

Key words: Colorectal neoplasms, Prognosis, Mucinous adenocarcinoma, Heterogenicity

Manxiang Wang, Qiongrong Chen. The heterogenicity of mucinous colorectal adenocarcinoma and its association with prognosis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(05): 428-433.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2016.05.012

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2016/V05/I05/428

Figures/Tables 2

References 38

[1]	Jimi Sei-ichiro,Masayuki Hotokezaka,Takuto Ikeda, et al. Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma[J]. Surg Today, 2015, 45(3): 329-334.
[2]	Hamilton SR,Bosman FT,Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT,Carneiro F,Hruban RH,Theise ND, eds. WHO Classification of Tumours of the Digestive System[M]. 4th Edition. Lyon: IARC Press, 2010: 134-146.
[3]	Viganò L,Russolillo N,Ferrero A, et al.Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study[J].Ann Surg,2014, 260(5): 878-884.
[4]	Park JS,Huh JW,Park YA, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer[J]. Medicine (Baltimore), 2015, 94(15): e658.
[5]	Yoon YS,Kim J,Hong SM,et al. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer[J].Colorectal Dis, 2015, 17(8): O161-167.
[6]	Lupinacci RM,Mello ES,Coelho FF, et al. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases[J]. Surgery, 2014, 155(6): 1062-1068.
[7]	Debunne H,Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects[J]. Acta Chir Belg, 2013, 113(6): 385-390.
[8]	Verhulst J,Ferdinande L,Demetter P, et al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis[J]. J ClinPathol, 2012, 65(5): 381-388.
[9]	Yamaguchi T,Taniguchi H,Fujita S, et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma[J]. Histopathology, 2012, 61(2): 162-169.
[10]	Ooki A,Akagi K,Yatsuoka T, et al. Inverse effect of mucinous component on survival in stage III colorectal cancer[J]. J Surg Oncol, 2014,110(7): 851-857.
[11]	Yeo SA,Chew MH,Koh PK, et al. Inverse effect of mucinous component on survival in stage III colorectal cancer[J]. Tech Coloproctol, 2013, 17(6): 653-661.
[12]	Langner C,Harbaum L,Pollheimer MJ,et al. Mucinous differentiation in colorectal cancer--indicator of poor prognosis[J]? Histopathology, 2012, 60(7): 1060-1072.
[13]	Nervi M,Gambaccini D,Ambrosini CE, et al. Overall prognosis in younger patients with colorectal carcinoma[J].Minerva Chir, 2006, 61(5): 381-384.
[14]	Razenberg LG,van Gestel YR,Lemmens VE,et al. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study[J]. Clin Colorectal Cancer, 2015,14(4): e13-e19.
[15]	Hogan J,Burke JP,Samaha G, et al. Overall survival is improved in mucinous adenocarcinoma of the colon[J]. Int J Colorectal Dis, 2014, 29(5): 563-569.
[16]	Hyngstrom JR,Hu CY,Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base[J]. Ann SurgOncol, 2012, 19(9): 2814-2821.
[17]	Gao P,Song YX,Xu YY, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases[J]. Histopathology, 2013, 63(5): 603-615.
[18]	Safaee A,Moghimi-Dehkordi B,Fatemi SR et al. Characteristics of colorectal mucinous adenocarcinoma in Iran[J]. Asian Pac J Cancer Prev, 2010, 11(5): 1373-1375.
[19]	Chen JX,Tang XD,Xiang DB, et al. TNM stages and prognostic features of colorectal mucinous adenocarcinomas: a meta analysis[J]. Asian Pac J Cancer Prev, 2012, 13(7): 3427-3430.
[20]	Kang H,O'Connell JB,Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum[J]. Dis Colon Rectum, 2005, 48(6): 1161-1168.
[21]	Jivapaisarnpong P,Boonthongtho K. Clinicopathological characteristics of mucinous and non- mucinous adenocarcinoma in the colon andrectum in Rajavithi Hospital, Thailand[J]. J Med Assoc Thai, 2011, 94(Suppl 2): S41-S45.
[22]	Zlobec I,Bihl MP,Foerster A, et al. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer[J]. Histopathology, 2012, 61(5): 777-787.
[23]	Betge J,Kornprat P,Pollheimer MJ, et al. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer[J]. Ann SurgOncol, 2012, 19(12): 3706-3712.
[24]	Barresi V,ReggianiBonetti L,Ieni A, et al. Histological grading in colorectal cancer: new insights and perspectives[J]. HistolHistopathol, 2015, 30(9): 1059-1067.
[25]	Ueno H,Kajiwara Y,Shimazaki H, et al. New criteria for histologic grading of colorectal cancer[J]. Am J SurgPathol, 2012, 36(2): 193-201.
[26]	Ueno H,Hase K,Hashiguchi Y,et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters[J]. Am J Surg Pathol, 2014, 38(2): 197-204.
[27]	Barresi V,Bonetti LR,Ieni A, et al. Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients[J]. Hum Pathol, 2014, 45(2): 268-275.
[28]	Barresi V,ReggianiBonetti L,Branca G, et al. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading[J].Virchows Arch, 2012, 461(6): 621-628.
[29]	Ueno H,Shinto E,Kajiwara Y, et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer[J]. Br J Cancer, 2014, 111(11): 2082-2090.
[30]	Barresi V,ReggianiBonetti L,Ieni A, et al. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinousadenocarcinoma[J]. Hum Pathol, 2015, 46(11): 1722-1729.
[31]	Moreira L,Balaguer F,Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer[J]. JAMA, 2012, 308(15): 1555-1565.
[32]	Kane MF,Loda M,Gaida GM,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines[J]. Cancer Res, 1997, 57(5): 808-811.
[33]	Guastadisegni C,Colafranceschi M,Ottini L, et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data[J]. Eur J Cancer, 2010, 46(15): 2788-2298.
[34]	Benatti P,Gafà R,Barana D, et al. Microsatellite instability and colorectal cancer prognosis[J]. Clin Cancer Res, 2005, 11(23): 8332-8340.
[35]	Sinicrope FA,Rego RL,Halling KC, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients[J]. Gastroenterology, 2006, 131(3): 729-737.
[36]	Rosty C,Williamson EJ,Clendenning M, et al. Should the grading of colorectal adenocarcinoma include microsatellite instability status[J]? Hum Pathol,2014, 45(10): 2077-2084.
[37]	Barresi V,Bonetti LR. Correlation between microsatellite instability status and grading assessed by the counting of poorly differentiated clusters in colorectal cancer[J]. Hum Pathol, 2015, 46(7): 1063.
[38]	秦云,梁莉萍,郑兴征,等.免疫组织化学法检测结直肠癌四种DNA错配修复蛋白表达缺失对判断肿瘤微卫星状态的价值[J]. 中华病理学杂志, 2015, 44(10): 704-708.

Please choose a citation manager

Content to export